Literature DB >> 3068338

The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies.

G S Cooper1, D J Jeffers.   

Abstract

Thirty-two follow-up studies of patients with HIV-1 infection, but without AIDS at baseline, were examined for information on the risk of developing AIDS or other conditions. Disease progression in asymptomatic groups was similar to that found in patients with persistent generalized lymphadenopathy (PGL) without other symptoms. Among these asymptomatic and PGL groups, the risk of developing AIDS reached 10% to 15% between 24 and 36 months of follow up. The risk of progression to AIDS continued to increase in the studies with longer follow-up periods, reaching 36% at 88 months. However, more than 40% of "high-risk" groups (characterized by the presence of constitutional symptoms, oral thrush, herpes zoster, and/or low T4 counts) developed AIDS after only 36 months of follow-up. Reliable information about progression to other states (e.g., AIDS-related complex) has not been consistently provided.

Entities:  

Mesh:

Year:  1988        PMID: 3068338     DOI: 10.1007/bf02596093

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

1.  AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations.

Authors:  M V Ragni; G E Tegtmeier; J A Levy; L S Kaminsky; J H Lewis; J A Spero; F A Bontempo; C Handwerk-Leber; W L Bayer; D H Zimmerman
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

2.  The medical review article: state of the science.

Authors:  C D Mulrow
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

3.  Human immunodeficiency virus infection in hemophilia patients: a 4-year prospective study.

Authors:  E Beth-Giraldo; G Giraldo; R De Biasi; E Miraglia; G Castello; M Monaco; M Perna; D Zarrilli; M Piazza; P Tullio Cataldo
Journal:  Antibiot Chemother (1971)       Date:  1987

4.  Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation.

Authors:  K Schwartz; B R Visscher; R Detels; J Taylor; P Nishanian; J L Fahey
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

5.  Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.

Authors:  F de Wolf; J Goudsmit; D A Paul; J M Lange; C Hooijkaas; P Schellekens; R A Coutinho; J van der Noordaa
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

6.  Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.

Authors:  J K Nicholson; J S McDougal; H W Jaffe; T J Spira; M S Kennedy; B M Jones; W W Darrow; M Morgan; M Hubbard
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

7.  Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndrome.

Authors:  U Mathur-Wagh; R W Enlow; I Spigland; R J Winchester; H S Sacks; E Rorat; S R Yancovitz; M J Klein; D C William; D Mildvan
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

8.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.

Authors:  J J Goedert; R J Biggar; M Melbye; D L Mann; S Wilson; M H Gail; R J Grossman; R A DiGioia; W C Sanchez; S H Weiss
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

9.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

Review 10.  Unexplained persistent lymphadenopathy in homosexual men and the acquired immune deficiency syndrome.

Authors:  J W Gold; C S Weikel; J Godbold; C Garcia; C Urmacher; S Cunningham-Rundles; B Koziner; M Pollack; R C Gallo; M G Sarngadharan
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

View more
  2 in total

1.  Zidovudine prophylaxis for needlestick exposure to human immunodeficiency virus: a decision analysis.

Authors:  H S Sacks; D N Rose
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

2.  Weight loss might be an early clinical feature of undiagnosed human immunodeficiency virus infection in Taiwan.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Biomedicine (Taipei)       Date:  2018-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.